• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

251.64 -2.67 (-1.05%)
Official Closing Price Updated: 7:00 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,999,721
Open 255.00
Bid (Size) 250.02 (200)
Ask (Size) 251.50 (100)
Prev. Close 254.31
Today's Range 250.10 - 255.50
52wk Range 181.75 - 255.99
Shares Outstanding N/A
Dividend Yield 2.75%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy? ↗
June 30, 2026
AbbVie knows how to plan ahead. 
Via The Motley Fool
Topics Intellectual Property
News headline image
3 No-Brainer Dividend Stocks to Buy Right Now ↗
June 29, 2026
AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+9.7%
+9.7%
1 Month
+18.2%
+18.2%
3 Month
+15.7%
+15.7%
6 Month
+9.5%
+9.5%
1 Year
+35.6%
+35.6%

More News

Read More
News headline image
AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy? ↗
June 29, 2026
Via The Motley Fool
AbbVie Inc (NYSE:ABBV) Breakout Setup Combines Strong Technical Rating with High-Quality Consolidation Entry ↗
June 17, 2026
Via Chartmill
News headline image
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
June 29, 2026
Via StockStory
Topics Retirement Stocks
News headline image
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026? ↗
June 25, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Is AbbVie a Buy After Its Purchase of Apogee? ↗
June 25, 2026
Via The Motley Fool
News headline image
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From Biotech Insider
Via GlobeNewswire
News headline image
Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years ↗
June 24, 2026
Via Benzinga
News headline image
2 Value Stocks Worth Your Attention and 1 Facing Headwinds
June 24, 2026
Via StockStory
News headline image
3 Monster Stocks to Hold for the Next 10 Years ↗
June 23, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Why AbbVie Stock Jumped Today ↗
June 22, 2026
Via The Motley Fool
News headline image
AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King? ↗
June 22, 2026
Via The Motley Fool
Monday's session: top gainers and losers in the S&P500 index ↗
June 22, 2026
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)
June 22, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
Explore the top gainers and losers within the S&P500 index in today's session. ↗
June 22, 2026
Via Chartmill
News headline image
5 Dividend Stocks to Buy and Hold Forever ↗
June 22, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Excellent Dividend Stocks to Buy on the Dip ↗
June 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy Intellectual Property
News headline image
2 Profitable Stocks Worth Your Attention and 1 We Avoid
June 22, 2026
Via StockStory
News headline image
How Many Botox Units Do You Need: Forehead, Crow's Feet, and Frown Lines
June 18, 2026
Via Press Release Distribution Service
News headline image
3 High-Yield Dividend Stocks to Buy Hand Over Fist in June ↗
June 15, 2026
Via The Motley Fool
Topics Economy
News headline image
Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock? ↗
June 12, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend. ↗
June 12, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500? ↗
June 08, 2026
Via The Motley Fool
Topics Intellectual Property Stocks
News headline image
The Best Stocks to Invest $500 in Right Now ↗
June 04, 2026
Via The Motley Fool

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 251.64
When was AbbVie last traded?
The last trade of AbbVie was at 06/30/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap